\-\ Texto\\:\\ \ \(0\)\
\-\ none\ \(204\)\
\-\ 1\\.\\ axial\\ ct\\ images\\ that\\ were\\ obtained\\ in\\ the\\ normal\\ abdominal\\ protocol\\.\\ \\ the\\ images\\ are\\ in\\ arterial\\ phase\\ as\\ seen\\ by\\ the\\ contrast\\ filled\\ aorta\\.\\ \\ the\\ liver\\ is\\ abnormally\\ heterogenous\\ in\\ attenuation\\.\\ \\ the\\ next\\ image\\ shows\\ the\\ abnormal\\ increase\\ attenuation\\ of\\ the\\ hepatic\\ veins\\.\\ \\ the\\ next\\ image\\ shows\\ enlarge\\ portal\\ vein\\ and\\ as\\ the\\ vein\\ reaches\\ the\\ periphery\\,\\ there\\ is\\ pooling\\ of\\ the\\ contrast\\.\\ \\ the\\ last\\ image\\ shows\\ a\\ large\\ common\\ hepatic\\ artery\\.\\ \\ these\\ findings\\ are\\ consistent\\ with\\ arterial\\ venous\\ shunting\\ which\\ may\\ be\\ caused\\ by\\ hereditary\\ hemorrhagic\\ telangiectasia\\ or\\ a\\ diffuse\\ neoplastic\\ process\\.\\ \\ the\\ patient\\ has\\ a\\ history\\ of\\ \\ hereditary\\ hemorrhagic\\ telangiectasia\\ and\\ cutaneous\\ lesions\\.\ \(0\)\
\-\ hereditary\\ hemorrhagic\\ telangiectasia\\ \\(hht\\)\\ and\\ pulmonary\\ arteriovenous\\ malformation\\ \\(avm\\)\ \(0\)\
\-\ 1\\.\\ arterial\\ venous\\ malformation\ \(1\)\
\-\ 2\\.\\ diffuse\\ hepatic\\ cellular\\ carcinoma\\ or\\ diffuse\\ metastatic\\ disease\ \(1\)\
\-\ rule\\ out\\ diverticular\\ disease\\ in\\ patient\\ with\\ abdominal\\ pain\ \(0\)\
\-\ see\\ factoid\\.\ \(59\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ telangiectasia\\:\\ 0\\.11242199973200795\ \(0\)\
\-\ hereditary\\:\\ 0\\.09552263802347438\ \(0\)\
\-\ hemorrhagic\\:\\ 0\\.07767281857138046\ \(0\)\
\-\ arterial\\:\\ 0\\.07286385601427281\ \(0\)\
\-\ hepatic\\:\\ 0\\.06951612373648075\ \(0\)\
\-\ next\\:\\ 0\\.056340020902445345\ \(0\)\
\-\ image\\:\\ 0\\.051997191551251966\ \(0\)\
\-\ diffuse\\:\\ 0\\.050396248448869765\ \(0\)\
\-\ hht\\:\\ 0\\.04679273059436622\ \(0\)\
\-\ shows\\:\\ 0\\.045767020124588546\ \(0\)\
\-\ attenuation\\:\\ 0\\.04461845546007843\ \(0\)\
\-\ diverticular\\:\\ 0\\.04460784594098172\ \(0\)\
\-\ malformation\\:\\ 0\\.044264242240342595\ \(0\)\
\-\ reaches\\:\\ 0\\.04110786866349674\ \(0\)\
\-\ pooling\\:\\ 0\\.04058811082146079\ \(0\)\
\-\ venous\\:\\ 0\\.040282930109832846\ \(0\)\
\-\ vein\\:\\ 0\\.04015497820797555\ \(0\)\
\-\ enlarge\\:\\ 0\\.04010689022306\ \(0\)\
\-\ cellular\\:\\ 0\\.03717192188706612\ \(0\)\
\-\ shunting\\:\\ 0\\.035378068792078075\ \(0\)\
\-\ 1\\.\\:\\ 0\\.03466479436750131\ \(0\)\
\-\ cutaneous\\:\\ 0\\.03224266767698987\ \(0\)\
\-\ periphery\\:\\ 0\\.030990046468389276\ \(0\)\
\-\ abnormally\\:\\ 0\\.03054963999865706\ \(0\)\
\-\ protocol\\:\\ 0\\.029844225446690856\ \(0\)\
\-\ portal\\:\\ 0\\.029207989028767457\ \(0\)\
\-\ arteriovenous\\:\\ 0\\.02912198106285823\ \(0\)\
\-\ heterogenous\\:\\ 0\\.028472088474825873\ \(0\)\
\-\ neoplastic\\:\\ 0\\.028395241347247933\ \(0\)\
\-\ abdominal\\:\\ 0\\.027739210884702797\ \(0\)\
\-\ veins\\:\\ 0\\.026546302631520503\ \(0\)\
\-\ avm\\:\\ 0\\.026432378542878235\ \(0\)\
\-\ phase\\:\\ 0\\.0261021290803231\ \(0\)\
\-\ filled\\:\\ 0\\.025787865827973426\ \(0\)\
\-\ contrast\\:\\ 0\\.024841242685816955\ \(0\)\
\-\ aorta\\:\\ 0\\.02381833731917562\ \(0\)\
\-\ last\\:\\ 0\\.023706054870408992\ \(0\)\
\-\ increase\\:\\ 0\\.023275388357869558\ \(0\)\
\-\ caused\\:\\ 0\\.023275388357869558\ \(0\)\
\-\ rule\\:\\ 0\\.023172041245493588\ \(0\)\
\-\ process\\:\\ 0\\.02136406158983581\ \(0\)\
\-\ images\\:\\ 0\\.021289141453887717\ \(0\)\
\-\ obtained\\:\\ 0\\.01972640325158339\ \(0\)\
\-\ factoid\\:\\ 0\\.019450879828663226\ \(0\)\
\-\ liver\\:\\ 0\\.019131308511900803\ \(0\)\
\-\ by\\:\\ 0\\.01847884289928409\ \(0\)\
\-\ out\\:\\ 0\\.018338012187392963\ \(0\)\
\-\ disease\\:\\ 0\\.018139448587216937\ \(0\)\
\-\ 2\\.\\:\\ 0\\.017645741180521157\ \(0\)\
\-\ as\\:\\ 0\\.016786720855767896\ \(0\)\
\-\ see\\:\\ 0\\.01655985202096616\ \(0\)\
\-\ artery\\:\\ 0\\.016522922026676618\ \(0\)\
\-\ pulmonary\\:\\ 0\\.016211365650779633\ \(0\)\
\-\ axial\\:\\ 0\\.01583630828615501\ \(0\)\
\-\ abnormal\\:\\ 0\\.015825274287759164\ \(0\)\
\-\ carcinoma\\:\\ 0\\.015726803052051083\ \(0\)\
\-\ are\\:\\ 0\\.01512823211077405\ \(0\)\
\-\ lesions\\:\\ 0\\.014854289002233428\ \(0\)\
\-\ common\\:\\ 0\\.014521215662054528\ \(0\)\
\-\ these\\:\\ 0\\.014440549947778183\ \(0\)\
\-\ metastatic\\:\\ 0\\.013968242880623963\ \(0\)\
\-\ none\\:\\ 0\\.013764412382519525\ \(0\)\
\-\ consistent\\:\\ 0\\.013605832914488334\ \(0\)\
\-\ or\\:\\ 0\\.013006788947580618\ \(0\)\
\-\ were\\:\\ 0\\.012599261926557932\ \(0\)\
\-\ may\\:\\ 0\\.012170963434403402\ \(0\)\
\-\ large\\:\\ 0\\.012133392414487531\ \(0\)\
\-\ findings\\:\\ 0\\.011810629453181556\ \(0\)\
\-\ the\\:\\ 0\\.011670394163293086\ \(0\)\
\-\ patient\\:\\ 0\\.011124570531381663\ \(0\)\
\-\ seen\\:\\ 0\\.010965114383556431\ \(0\)\
\-\ in\\:\\ 0\\.010945382601045583\ \(0\)\
\-\ has\\:\\ 0\\.010420129678534272\ \(0\)\
\-\ which\\:\\ 0\\.010358081735341225\ \(0\)\
\-\ that\\:\\ 0\\.009584290445187165\ \(0\)\
\-\ \\(\\:\\ 0\\.009381321120050138\ \(0\)\
\-\ \\)\\:\\ 0\\.009266723274198767\ \(0\)\
\-\ normal\\:\\ 0\\.008698782172721437\ \(0\)\
\-\ be\\:\\ 0\\.008556861839895645\ \(0\)\
\-\ there\\:\\ 0\\.008257893223798628\ \(0\)\
\-\ ct\\:\\ 0\\.007761712035013266\ \(0\)\
\-\ a\\:\\ 0\\.007725970165297427\ \(0\)\
\-\ history\\:\\ 0\\.007663730764331711\ \(0\)\
\-\ is\\:\\ 0\\.0073024776413600735\ \(0\)\
\-\ pain\\:\\ 0\\.0067766764125372385\ \(0\)\
\-\ and\\:\\ 0\\.0035066689428354244\ \(0\)\
\-\ of\\:\\ 0\\.0022695545609997744\ \(0\)\
\-\ \\.\\:\\ 0\\.0020746482134812757\ \(0\)\
\-\ \\,\\:\\ 0\\.001757857568294074\ \(0\)\
\-\ with\\:\\ 0\\.0015195347544141526\ \(0\)\
